Journal of Medicinal Chemistry · 2022 · 31 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryPharmacophore ModelingAntibacterial AgentsAntibacterial PharmacologyEnzyme InhibitionLigand-based DesignPharmacophore-based Lead DiscoveryTuberculosis PharmacotherapyCytotoxicity AssaysIn Vivo Efficacy TestingPharmacophore Model ConstructionPharmacophore Model OptimizationPharmacophore Model RefinementStructure-activity Relationship ModelingStructure-guided DesignTuberculosis Drug Resistance
In this work, pyrrole-2-carboxamides were designed with a structure-guided strategy based on the crystal structure of MmpL3 and a pharmacophore model. The structure–activity relationship studies revealed that attaching phenyl and pyridyl groups with electron-withdrawing substituents to the pyrrole ring and attaching bulky substituents to the carboxamide greatly improved anti-TB activity. Most compounds showed potent anti-TB activity (MIC < 0.016 μg/mL) and low cytotoxicity (IC50 > 64 μg/mL). Compound 32 displayed excellent activity against drug-resistant tuberculosis, good microsomal stability, almost no inhibition of the hERG K+ channel, and good in vivo efficacy. Furthermore, the target of the pyrrole-2-carboxamides was identified by measuring their potency against M. smegmatis expressing wild-type and mutated variants of the mmpL3 gene from M. tuberculosis (mmpL3tb) and determining their effect on mycolic acid biosynthesis using a [14C] acetate metabolic labeling assay. The present study provides new MmpL3 inhibitors that are promising anti-TB agents.
21
Kapil Tahlan, Regina Wilson, David B. Kastrinsky et al. · Antimicrobial Agents and Chemotherapy · 2012 · 504 citations · Full text
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
Bing Zhang, Jun Li, Xiaolin Yang et al. · Cell · 2019 · 258 citations · Full text